[Myelodysplastic/myeloproliferative neoplasia: a diagnostic and therapeutic challenge]

Area of Science:

• Hematology
• Oncology

Background:

• Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are a WHO-defined group of hematologic malignancies.
• Diagnosis is challenging due to overlapping features with inflammation, dysplasia, and proliferation.
• Treatment requires balancing proliferation control with avoiding aggravation of cytopenia.

Purpose of the Study:

• To provide an overview of MDS/MPN.
• To focus on diagnostic and therapeutic challenges.
• To specifically discuss Chronic Myelomonocytic Leukemia (CMML) and MDS/MPN with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T).

Main Methods:

• Literature review and synthesis of current knowledge.
• Focus on diagnostic criteria and differential diagnosis.
• Discussion of therapeutic strategies and their complexities.

Main Results:

• MDS/MPN entities share overlapping clinical, morphologic, and genetic features.
• Distinguishing between MDS/MPN and other conditions requires careful evaluation.
• Therapeutic approaches must be individualized based on specific subtype and patient factors.

Conclusions:

• Accurate diagnosis of MDS/MPN is crucial for appropriate management.
• Therapeutic strategies for MDS/MPN are complex and evolving.
• Further research is needed to improve diagnostic accuracy and treatment outcomes for these rare hematologic malignancies.